In order to elevate patient care for migraine, it is imperative that headache specialists gain expertise in clinical trial data for new therapies, mechanisms of action, and clinical practice standards. This is especially true as we approach the first year of monoclonal antibodies being available in clinical practice that block the activity of calcitonin gene-related peptide. Competency in patient engagement strategies will serve as a lever to propel the expanding knowledge base into meaningful change in migraine-patient care.
- July 25, 2019, Lake Buena Vista, Florida
- 60-minute live forum featuring Microsoft HoloLens, a mixed reality device
- Review of clinical cases, applications to clinical decision making, and shared decision making techniques
- Delivered in conjunction with Diamond Headache Clinic Research & Educational Foundation Meeting, Headache Update
Educate headache specialists on the pathophysiology and mechanisms of action of acute and preventive migraine treatments.